Imidafenacin
Overview of the antimuscarinic drug Imidafenacin
| Imidafenacin | |
|---|---|
|
| |
| Chemical nomenclature | |
| IUPAC name | 4-(2-methyl-1H-imidazol-1-yl)-2,2-diphenylbutanamide
|
Imidafenacin is a medication used primarily in the treatment of overactive bladder (OAB). It is classified as an antimuscarinic agent, which works by inhibiting the action of acetylcholine on muscarinic receptors in the bladder, thereby reducing urinary urgency, frequency, and incontinence.
Pharmacology[edit]
Imidafenacin is a selective antagonist for the M3 and M1 subtypes of muscarinic receptors. These receptors are predominantly found in the bladder and salivary glands. By blocking these receptors, imidafenacin reduces involuntary bladder contractions and increases bladder capacity.
Mechanism of Action[edit]

The mechanism of action of imidafenacin involves competitive inhibition of muscarinic receptors. This inhibition decreases the detrusor muscle contractions of the bladder, which are responsible for the symptoms of overactive bladder. The selectivity for M3 receptors helps in minimizing side effects such as dry mouth and constipation, which are common with non-selective antimuscarinics.
Clinical Use[edit]
Imidafenacin is indicated for the management of overactive bladder with symptoms of urgency, frequency, and urge incontinence. It is administered orally and is available in tablet form. The typical dosage is 0.1 mg twice daily, but the dosage may be adjusted based on patient response and tolerability.
Side Effects[edit]
Common side effects of imidafenacin include dry mouth, constipation, and blurred vision. These effects are due to its anticholinergic properties. Less common side effects may include urinary retention, dizziness, and headache.
Contraindications[edit]
Imidafenacin is contraindicated in patients with urinary retention, gastric retention, uncontrolled narrow-angle glaucoma, and in those who have demonstrated hypersensitivity to the drug or its components.
Related pages[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian